Pharmaceuticals

Liberian government receives approval for the use of experimental Ebola drug

PCR-Online-August-EbolaThe Liberian government has received approval from the US Food and Drug Administration (FDA) for the use of an experimental serum on two Liberian medical doctors who are fighting for their lives after contracting the deadly Ebola virus disease.

Conference elaborates on pharmaceutical industry's pain points

 

Connie Tloubatla, director of Bliss Pharmaceuticals, elaborated on the future of pharmaceutical manufacturing in emerging markets on day three of the PharmaCon conference.PharmaCon 2014 featured speakers from various sectors of the South African pharmaceutical industry, including the regulatory, manufacturing and patent sides of this business.

NAPM new Executive Council to intensify efforts to ensure generic medicine access

The NAPM comprises generics-based pharmaceutical manufacturers and distributors and aims to improve access to affordable quality medicines

The National Association of Pharmaceutical Manufacturers (NAPM) announced the appointment of its new Executive Council (EXCO), which has been tasked with strengthening the association’s strategic position within the pharmaceutical industry while representing the interests of its members and the broader public.

Sandoz joins forces with UN to combat a leading cause of child mortality worldwide

PCR-Online-August-SandozSandoz has made a long-term commitment to help prevent the deaths of millions of children worldwide by supplying a key antibiotic formulation, as part of the United Nation’s new Every Newborn Action Plan.

EffRx signs Binosto distribution agreements in Russia and Africa

EffRx signs_Binosto_distribution_agreements_in_Russia_and_AfricaThe specialty pharmaceutical company, EffRx Pharmaceuticals (EffRx) has signed two new distribution agreements that will bring its osteoporosis treatment, Binosto, to strategic markets in Africa, Russia and Commonwealth of Independent States countries.

Would you like to receive our FREE e-newsletter?

* indicates required
Close